CervoMed Inc. logo

CervoMed Inc.

CRVO | NASDAQ
Chart Builder DCF Calculator
$2.54
+$0.13 (+5.39%)
Sep 22, 2026, 3:51 PM ET · Market open

Market Data

Market Cap
$22.31M
Enterprise Value
$-2.62M
Beta
-4.31
Average Volume
5.63M
Shares Outstanding (Diluted)
10.24M
Shares Change YoY
14.46%
Institutional Ownership
19.11%
Exchange
NASDAQ
ISIN
US15713L1098

Price Performance

Price Change 1M
-9.1%
Price Change 3M
-35.2%
Price Change 6M
-40.4%
Price Change YTD
-69.1%
Price Change 1Y
-70.5%
Price Change 3Y
-44.5%
Price Change 5Y
-93.6%
1M CAGR (ann.)
-16.0%
1Y CAGR (ann.)
-70.3%
5Y CAGR (ann.)
-43.1%
All-Time CAGR
-58.3%

Valuation

PE Ratio
-0.75
Forward PE
N/A
PEG Ratio
0.03
Forward PEG
0.02
PS Ratio
69.17
Forward PS
22.30
PB Ratio
0.97
P/FCF Ratio
-0.80
P/Adj. FCF Ratio
-0.77
P/OCF Ratio
-0.88
EV/Sales
-8.14
EV/EBIT
0.11
EV/EBITDA
0.09
EV/FCF
0.09
Earnings Yield
-133.2%
FCF Yield
-125.4%
Adj. FCF Yield
-129.9%

Financial Health

Net Cash
$24.94M
Total Debt
$0
Cash & Short-Term Investments
$24.94M
Total Assets
$25.99M
Current Ratio
8.57
Quick Ratio
8.57
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-3.58
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-9661.4%
EBITDA Margin
-9408.8%
Net Profit Margin
-9408.8%
FCF Margin
-8673.4%
Adj. FCF Margin
-8984.4%
SBC / Revenue
311.0%
SBC Impact (per share)
-3.6%

Returns

Return on Assets
-116.8%
Return on Equity
-156.0%
Return on Invested Capital
-135.7%
Return on Capital Employed
-135.7%
Return on Tangible Assets
-116.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.0%
Revenue CAGR 5Y
100.0%
Revenue CAGR 10Y
54.5%
EPS CAGR 3Y
-27.9%
EPS CAGR 5Y
52.0%
EPS CAGR 10Y
51.6%
FCF CAGR 3Y
-67.2%
FCF CAGR 5Y
-35.8%
FCF CAGR 10Y
-8.3%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
7
EPS Growth Next 3Y
26.6%
Revenue Growth Next 3Y
175.4%
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$0.61
EPS Growth Est (next Q)
-27.4%
Revenue Est (next Q)
$50K
Revenue Growth Est (next Q)
-84.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$7
Price Target Upside
190.5%

Cash Flow

Operating Cash Flow
$-27.98M
Free Cash Flow
$-27.98M
Adj. Free Cash Flow
$-28.98M
FCF Per Share
-$2.73
OCF Per Share
-$2.73
OCF/S Ratio
-8673.4%

Income Statement

Revenue
$322.57K
Gross Profit
$322.57K
Operating Income
$-31.16M
EBITDA
$-30.46M
Net Income
$-30.35M
EPS (Diluted)
-$3.21
Revenue / Employee
$21.5K
Profit / Employee
$-2.02M
Employees
15

© 2026 bestshares.com. All rights reserved.